2 results match your criteria: "a Medical University of Lodz[Affiliation]"
Patient safety initiatives in Central and Eastern Europe: A mixed methods approach by the LINNEAUS collaboration on patient safety in primary care.
Eur J Gen Pract
September 2015
a Medical University of Lodz, Department of Family and Community Medicine , Lodz , Poland.
Background: Despite patient safety being recognized as an important healthcare issue in the European Union, there has been variable implementation of patient safety initiatives in Central and Eastern Europe (CEE).
Objective: To assess the status of patient safety initiatives in countries in CEE; to describe a process of engagement in Poland, which can serve as a template for the implementation of patient safety initiatives in primary care.
Methods: A mixed methods design was used.
Emerging immunological drugs for chronic lymphocytic leukemia.
Expert Opin Emerg Drugs
September 2015
a Medical University of Lodz, Departments of Experimental Hematology and Hematology, Copernicus Memorial Hospital, 93-510 Lodz, Ul. Ciolkowskiego 2, Poland +48 42 689 51 91 ; +48 42 689 51 92 ;
Introduction: Over the last few years, several new immunological drugs, particularly monoclonal antibodies (mAbs), immunomodulatory drugs and B-cell receptor (BCR) pathway inhibitors have been developed and investigated in chronic lymphocytic leukemia (CLL). This article summarizes recent discoveries regarding their mechanism of action, pharmacological properties, clinical activity and toxicity, as well as the emerging role of these agents in CLL.
Areas Covered: A literature review of mAbs, BCR pathway inhibitors and immunomodulating drugs was conducted of the MEDLINE database via PubMed for articles in English.